ENHANCED T-CELL REACTIVITY TO INSULIN PEPTIDE A1-12 IN CHILDREN WITH RECENTLY DIAGNOSED TYPE 1 DIABETES OR DIABETES ASSOCIATED AUTOANTIBODIES

スポンサーリンク

概要

論文の詳細を見る
2005-10-01

著者

関連論文

MATERNAL ENTEROVIRUS ANTIBODIES IN BREAST MILK PROTECT THE CHILD FROM ENTEROVIRUS INFECTIONS-RESULTS FROM THE TRIGR (PILOT 2) TRIAL
DIETARY INSULIN AS AN IMMUNOGEN AND TOLEROGEN
POOR IN VITRO INDUCTION OF Treg CELLS IN TYPE 1 CYTOKINE ENVIRONMENT IN CHILDREN WITH RECENTLY DIAGNOSED TYPE 1 DIABETES
FEASIBILITY OF A PLACEBO-CONTROLLED DOUBLE-BLINDED TYPE 1 DIABETES (T1D) PREVENTION TRIAL TESTING EFFICACY OF NASAL INSULIN IN A POPULATION-BASED COHORT OF CHILDREN WITH HLA-CONFERRED T1D RISK AND MULTIPLE AUTOANTIBODIES
ENTEROVIRUS ANALYSES FROM PANCREATIC TISSUE OF A CHILD POSITIVE FOR DIABETES-ASSOCIATED AUTOANTIBODIES
ANALYSIS OF REGULATORY CD4^+CD25^ T-CELLS AND NATURAL KILLER T-CELLS IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES AND IN AUTOANTIBODY-POSITIVE SUBJECTS
PTPN22 LYMPHOID TYROSINE PHOSPHATASE Arg620Trp VARIANT REGULATES INSULIN AUTOIMMUNITY AND PROGRESSION TO TYPE 1 DIABETES
ENHANCED T-CELL REACTIVITY TO INSULIN PEPTIDE A1-12 IN CHILDREN WITH RECENTLY DIAGNOSED TYPE 1 DIABETES OR DIABETES ASSOCIATED AUTOANTIBODIES
TEMPORAL SEASONALITY IN EMERGENCE OF DIABETES-ASSOCIATED AUTOANTIBODIES IN CHILDREN
THE RATE OF EMERGENCE OF AUTOANTIBODIES IS STABLE BETWEEN 6 MONTHS AND AT LEAST 8 YEARS OF AGE BUT DEPENDS ON HLA-CONFERRED RISK IN A PROSPECTIVELY FOLLOWED-UP POPULATION-BASED BIRTH COHORT
DECREASED in vitro TYPE 1 IMMUNE RESPONSE AGAINST COXSACKIE VIRUS B4 IN CHILDREN WITH TYPE 1 DIABETES
SHORT DURATION OF BREASTFEEDING AS A RISK-FACTOR FOR BETA-CELL AUTOANTIBODIES IN FIVE-YEAR-OLD HEALTHY CHILDREN
PROBIOTICS FOR THE PREVENTION OF BETA-CELL AUTOIMMUNITY IN CHILDREN AT GENETIC RISK OF TYPE 1 DIABETES - PRODIA STUDY
ATOPIC SYMPTOMS AND BETA-CELL AUTOIMMUNITY DURING THE FIRST TWO YEARS OF LIFE

もっと見る

スポンサーリンク